<DOC>
	<DOCNO>NCT03006341</DOCNO>
	<brief_summary>The objective study , first , identify select clinical covariates electronic medical record ( EMR ) might associate initiation oral anticoagulant medication ( dabigatran warfarin ) patient non-valvular atrial fibrillation ( NVAF ) risk stroke ; second , quantify association EMR-based clinical characteristic pattern insurance claim ; third , assess potential unmeasured confound dabigatran v warfarin comparative effectiveness safety study base administrative claim database .</brief_summary>
	<brief_title>Validation Predictors OAC Initiation Using EMR Data</brief_title>
	<detailed_description />
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Dabigatran</mesh_term>
	<criteria>First dispense warfarin dabigatran October 2010 December 2014 Diagnosis atrial fibrillation ≥ 12 month enrolment database precede date first dispense Age ≥ 18 CHA2DS2VASc score ≥ 1 Prior use oral anticoagulation Evidence valvular atrial fibrillation Missing ambiguous age sex information Patients nursing home stay baseline</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>